… in non-hospitalized COVID-19 patients remains uncertain … ) between COVID-19 and
non-COVID-19 non-hospitalized patients … risk in non-hospitalized COVID-19 patients considering …

… on COVID-19 therapeutics for nonhospitalized patients, we … -reduced if a patient with COVID-19
is treated with nirmatrelvir-… In fact, the University of Liverpool COVID-19 drug interaction …

… All patients included in this study had COVID-19 before vaccination … patients after
COVID-19 disease still remain largely elusive. In a previous CSF study of patients with post-COVID-19, …

… coronavirus disease 2019 (COVID-19), the so-called post-COVID-19, in non-hospitalized
patients … up to 12 months after COVID-19 in non-hospitalized patients and their impact on work …

… Most PASC research has focused on hospitalized COVID-19 patients with moderate to severe
… There were 303 non-hospitalized individuals with a positive lab-confirmed COVID-19 test …

… agents for early COVID-19 in nonhospitalized patients. … COVID-19 or COVID-19–compatible
symptoms and an epidemiologic link to a contact with laboratory-confirmed COVID-19. …

… Anti-SARS-CoV-2 monoclonal antibodies are mainstay COVID-19 therapeutics. Safety, …
Non-hospitalized adults were randomized 1:1 within 10 days of COVID-19 symptoms to …

… in the management of COVID-19 via its immunomodulatory … COVID-19 patients is unknown.
We aimed to evaluate the efficacy of Levamisole on clinical status of patients with COVID-19 …

… The patients in this study did not develop COVID-19 pneumonia or any other complication.
The latency time between COVID-19 symptoms and skin manifestations and the low positive …

… review of 242 hospitalized patients with symptomatic COVID-19 in China found … nonhospitalized
patients in this analysis was similar to previous reports of patients with mild COVID-19 …